Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Featured

News
Hypertension Tablets Recalled
11/20/2024
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing...
11/20/2024
Pharmacy Learning Network
News
Chewable Tablets Recalled
11/20/2024
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken...
11/20/2024
Pharmacy Learning Network
News
Supplement Pulled for Hidden Drug Ingredients
11/20/2024
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is...
11/20/2024
Pharmacy Learning Network
Quiz
Rates of Amyloid Pathology in MS
11/19/2024
True or False: Patients with MS have a higher rate of amyloid pathology compared to control subjects.
True or False: Patients with MS have a higher rate of amyloid pathology compared to control subjects.
True or False: Patients with MS...
11/19/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Pharmacy Owner Sentenced to Prison for $6.9 Million Insurance Fraud Scheme
11/18/2024
The US Attorney’s Office for the Eastern District of Michigan has announced the sentencing of a Dearborn Heights pharmacist to 2 years in federal prison.
The US Attorney’s Office for the Eastern District of Michigan has announced the sentencing of a Dearborn Heights pharmacist to 2 years in federal prison.
The US Attorney’s Office for the...
11/18/2024
Pharmacy Learning Network
News
FDA Proposes Removal of Oral Phenylephrine from OTC Nasal Decongestants
11/14/2024
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug...
11/14/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
Tackling Sedentary Behavior at Work
11/14/2024
In this installment of Talking Therapeutics, we discuss a new study that explores the effect of various interventions aimed at combating sedentary behavior on blood pressure and pulse wave velocity (PWV), a key marker of arterial stiffness.
In this installment of Talking Therapeutics, we discuss a new study that explores the effect of various interventions aimed at combating sedentary behavior on blood pressure and pulse wave velocity (PWV), a key marker of arterial stiffness.
In this installment of Talking...
11/14/2024
Pharmacy Learning Network
News
Opioid Analgesic Recalled
11/13/2024
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
11/13/2024
Pharmacy Learning Network
News
Prescription-Strength NSAID Recalled
11/13/2024
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling...
11/13/2024
Pharmacy Learning Network
News
Glass Particles Prompt Class I Recall for Injection
11/13/2024
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is...
11/13/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Michigan Attorney General Sues PBMs for Their Role in Opioid Crisis
11/11/2024
Michigan Attorney General Dana Nessel announced a lawsuit against pharmacy benefit managers (PBMs) OptumRX, and ExpressScripts for their role in contributing to the opioid epidemic in the state.
Michigan Attorney General Dana Nessel announced a lawsuit against pharmacy benefit managers (PBMs) OptumRX, and ExpressScripts for their role in contributing to the opioid epidemic in the state.
Michigan Attorney General Dana...
11/11/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

News

News
Hypertension Tablets Recalled
11/20/2024
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing business as Major Pharmaceuticals and Rugby Laboratories, is recalling 3 lots of hydralazine hydrochloride tablets. According to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report,...
The Harvard Drug Group, doing...
11/20/2024
Pharmacy Learning Network
News
Chewable Tablets Recalled
11/20/2024
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken tablets have prompted Cipla USA Inc. to recall a single lot of lanthanum carbonate chewable tablets, according to the November 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Reports of crushed and broken...
11/20/2024
Pharmacy Learning Network
News
Supplement Pulled for Hidden Drug Ingredients
11/20/2024
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is recalling 150 packages of its dietary supplement Trinity Gold for containing undeclared acetaminophen, diclofenac, and phenylbutazone, according to the November 20, 2024, US Food and Drug Administration (FDA)...
Trinity Gold Nutrition is...
11/20/2024
Pharmacy Learning Network
News
FDA Proposes Removal of Oral Phenylephrine from OTC Nasal Decongestants
11/14/2024
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.
The US Food and Drug...
11/14/2024
Pharmacy Learning Network
News
Opioid Analgesic Recalled
11/13/2024
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling bottles of morphine sulfate extended-release tablets for failing to meet impurity/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
11/13/2024
Pharmacy Learning Network
News
Prescription-Strength NSAID Recalled
11/13/2024
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling prescription-strength ibuprofen for failing to meet impurity/degradation specifications during 18-month stability testing.
Direct Rx is recalling...
11/13/2024
Pharmacy Learning Network
News
Glass Particles Prompt Class I Recall for Injection
11/13/2024
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is recalling vials of ascorbic acid solution for injection for containing glass particulate matter.
Staska Pharmaceuticals Inc. is...
11/13/2024
Pharmacy Learning Network
News
Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
Impurity Prompts Two Firms to Recall Tablets
11/06/2024
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet...
11/06/2024
Pharmacy Learning Network
News
OTC Antihistamine Recalled
11/06/2024
BLI International Inc. recalls superpotent chlorpheniramine maleate tablets with potential for serious harm.
BLI International Inc. recalls superpotent chlorpheniramine maleate tablets with potential for serious harm.
BLI International Inc. recalls...
11/06/2024
Pharmacy Learning Network

Commentary

Ann Latner Headshot
Commentary
Pharmacy Owner Sentenced to Prison for $6.9 Million Insurance Fraud Scheme
11/18/2024
The US Attorney’s Office for the Eastern District of Michigan has announced the sentencing of a Dearborn Heights pharmacist to 2 years in federal prison.
The US Attorney’s Office for the Eastern District of Michigan has announced the sentencing of a Dearborn Heights pharmacist to 2 years in federal prison.
The US Attorney’s Office for the...
11/18/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Michigan Attorney General Sues PBMs for Their Role in Opioid Crisis
11/11/2024
Michigan Attorney General Dana Nessel announced a lawsuit against pharmacy benefit managers (PBMs) OptumRX, and ExpressScripts for their role in contributing to the opioid epidemic in the state.
Michigan Attorney General Dana Nessel announced a lawsuit against pharmacy benefit managers (PBMs) OptumRX, and ExpressScripts for their role in contributing to the opioid epidemic in the state.
Michigan Attorney General Dana...
11/11/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Former Kentucky Pharmacist Sentenced to Prison for Health Care Fraud
11/04/2024
The US Attorney’s Office for the Eastern District of Kentucky announced the sentencing of a former pharmacist to prison for attempting to defraud Medicare and Medicaid by billing for medications that were never dispensed.
The US Attorney’s Office for the Eastern District of Kentucky announced the sentencing of a former pharmacist to prison for attempting to defraud Medicare and Medicaid by billing for medications that were never dispensed.
The US Attorney’s Office for the...
11/04/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
VA Pharmacist Charged With Diverting Controlled Substances
10/29/2024
Following an investigation by the Virginia Department of Health Professions, a Virginia pharmacist was charged with diverting thousands of prescription medications for personal use over a year-long period.
Following an investigation by the Virginia Department of Health Professions, a Virginia pharmacist was charged with diverting thousands of prescription medications for personal use over a year-long period.
Following an investigation by...
10/29/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Four Pharmacy Owners Convicted of $13 Million Insurance Fraud
10/23/2024
The United States Department of Justice has announced the conviction of 4 pharmacy owners for conspiracy to commit health care fraud and wire fraud.
The United States Department of Justice has announced the conviction of 4 pharmacy owners for conspiracy to commit health care fraud and wire fraud.
The United States Department of...
10/23/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Federal Trade Commission Sues the Big Three PBMs Over Insulin Pricing
10/21/2024
In late September 2024, the Federal Trade Commission brought action against Caremark, Express Scripts, and OptumRx, the 3 largest pharmacy benefit managers and their respective group purchasing agents.
In late September 2024, the Federal Trade Commission brought action against Caremark, Express Scripts, and OptumRx, the 3 largest pharmacy benefit managers and their respective group purchasing agents.
In late September 2024, the...
10/21/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Whistleblower Receives Almost $10 million in Oak Street Health Settlement
10/10/2024
In late September 2024, Oak Street Health, a subsidiary of CVS Health since 2023, agreed to pay $60 million to resolve allegations of an illegal Medicare Advantage patient recruitment scheme. The whistleblower who reported the illegal...
In late September 2024, Oak Street Health, a subsidiary of CVS Health since 2023, agreed to pay $60 million to resolve allegations of an illegal Medicare Advantage patient recruitment scheme. The whistleblower who reported the illegal...
In late September 2024, Oak...
10/10/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Lawmakers Fail to Keep Felon Pharmacist in Prison
09/27/2024
Former pharmacist Robert Courtney, who was sentenced for diluting prescription medications, was granted early release despite protests from victims and lawmakers.
Former pharmacist Robert Courtney, who was sentenced for diluting prescription medications, was granted early release despite protests from victims and lawmakers.
Former pharmacist Robert...
09/27/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Rite Aid Settles With California; Emerges From Bankruptcy
09/20/2024
It has been quite a year for Rite Aid. The chain filed for Chapter 11 bankruptcy and began closing over 500 stores nationwide since last Fall. The chain has now reached a settlement with the state of California and announced that it has...
It has been quite a year for Rite Aid. The chain filed for Chapter 11 bankruptcy and began closing over 500 stores nationwide since last Fall. The chain has now reached a settlement with the state of California and announced that it has...
It has been quite a year for...
09/20/2024
Pharmacy Learning Network
Ann Latner Headshot
Commentary
South Carolina Pharmacist Sentenced for Illegally Compounding Radioactive Drugs
09/16/2024
The United States Attorney’s Office for the District of South Carolina has announced that a pharmacist pleaded guilty to adulteration of a radioactive drug and has been sentenced. Access the Pharmlaw to view details of the case.
The United States Attorney’s Office for the District of South Carolina has announced that a pharmacist pleaded guilty to adulteration of a radioactive drug and has been sentenced. Access the Pharmlaw to view details of the case.
The United States Attorney’s...
09/16/2024
Pharmacy Learning Network

Interviews

Vishali Amin
Interview
The State of Drug Affordability Programs and Reformation Solutions
01/29/2024
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin,...
01/29/2024
Pharmacy Learning Network
Guy Headshot
Interview
Securing the Medical Supply Chain: Addressing RSV Drug Shortages With IoT-Enabled Condition Monitoring in the Health Care Industry
12/12/2023
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply...
12/12/2023
Pharmacy Learning Network
Interview
Systemic and Topical Treatments For Atopic Dermatitis
10/31/2023
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr...
10/31/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 2
10/26/2023
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a...
10/26/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 1
10/25/2023
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking...
10/25/2023
Pharmacy Learning Network
Interview
Once-Daily, Single-Tablet Combination Therapy of Macitentan, Tadalafil in the Management of Patients With PAH
10/21/2023
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James...
10/21/2023
Pharmacy Learning Network
Headshot of Anita Patel, PharmD, Walgreens
Interview
Impact of COVID-19 Vaccines on Patients, Health Systems
12/21/2022
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice...
12/21/2022
Integrated Healthcare Executive
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot of Nicole L Stout, DPT, CLT-LANA, FAPTA
Interview
Enhancing Distress Screening, Management Across Cancer Care Delivery Settings
11/23/2022
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA,...
11/23/2022
Pharmacy Learning Network
Headshot of Safiya Karim
Interview
Discussing Association of Medical Cannabis, Prescription Opioid Use Among Patients With Cancer
10/18/2022
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC,...
10/18/2022
Pharmacy Learning Network

Podcasts

PopHealth Perspectives Stephen Crystal Part 2
PopHealth Perspectives
Addressing Prescription Drug Pricing: Fixing an Unsustainable Situation
12/28/2023
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a...
12/28/2023
Pharmacy Learning Network
Crystal
Podcasts
Addressing Prescription Drug Pricing: The Urgent Need for Price Negotiation in Medicare
12/13/2023
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about...
12/13/2023
Pharmacy Learning Network
Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Drug Spending Trends: Biosimilars, COVID-19 Therapies, and More
09/28/2022
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice...
09/28/2022
Integrated Healthcare Executive
Headshot of Michael Ganio, ASHP, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Monkeypox Vaccines: Current Options, Considerations for Patient Education
09/28/2022
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS,...
09/28/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement